| 6/21/01 |
NEW ROCHE VIRAL DISEASES RESEARCH SITE TO BE ESTABLISHED IN PALO ALTO |
| 6/7/01 | NEW COMPUTATIONAL TECHNIQUE REDUCES GENETIC ANALYSIS FROM MONTHS TO MILLISECONDS |
| 6/4/01 |
ROCHE PHARMACEUTICALS RECEIVES A CITY OF PALO ALTO COMMUNITY STAR AWARD |
| 5/24/01 | ROCHE PHARMACEUTICALS TO HOST CANOPY'S NEXT TREE WALK |
| 5/17/01: | LEWIS JUDD JOINS ROCHE BIOSCIENCE SCIENTIFIC ADVISORY BOARD |
| 4/30/01 |
ROCHE TEAMS UP WITH CANOPY, PROVIDING LARGEST GRANT TO DATE PLUS VOLUNTEER SUPPORT |
| 4/2/01: |
SEVEN YEARS AFTER DISCOVERY IN PALO ALTO, VALCYTE™ RECEIVES FDA APPROVAL FOR TREATMENT OF AIDS-RELATED CMV RETINITIS |
| 1/31/01: | ROCHE PHARMACEUTICALS REDUCES ELECTRICITY USE BY 20 PERCENT DURING PEAK USAGE PERIODS |
| 1/24/01 |
DAVID LOWE, Ph.D., JOINS ROCHE PHARMACEUTICALS AS VP AND THERAPY AREA HEAD OF CENTRAL NERVOUS SYSTEM RESEARCH IN PALO ALTO |
| 11/15/00: | ROCHE RECEIVES NIH GRANT TO FUND NEW GENOTYPING TOOL EXPECTED TO SPEED PRACTICAL APPLICATIONS OF GENOME RESEARCH |
| 10/27/00: | NEW STUDY DISCOVERS KEY MECHANISM INVOLVED IN BLADDER CONTROL |
| 8/29/00: | AXON INSTRUMENTS ANNOUNCES ION CHANNEL SCREENING COLLABORATION WITH ROCHE BIOSCIENCE |
| 7/17/00: | PHARMACOPEIA ACHIEVES INITIAL SUCCESS IN DRUG DISCOVERY COLLABORATION WITH ROCHE BIOSCIENCE |
|
GEOFFREY LAWTON, PH.D., APPOINTED VICE PRESIDENT, CHEMISTRY AND PRECLINICAL SCIENCES, ROCHE BIOSCIENCE
|
|
| RECENT APPOINTMENTS AT ROCHE PALO ALTO | |
| PHARMACOPEIA, INC. ANNOUNCES NEW COLLABORATION WITH ROCHE BIOSCIENCE |
|
| RECENT APPOINTMENTS AT ROCHE PALO ALTO | |
| ROCHE PALO ALTO SELECTS CHEMDEX TO PROVIDE SCIENTIFIC PROCUREMENT SERVICES | |
| ARQULE COMPOUND REACHES PRE-IND STAGE WITH ROCHE BIOSCIENCE | |
| AVENIDAS PRESENTS CERTIFICATE OF APPRECIATION TO ROCHE PALO ALTO | |
| AURORA BIOSCIENCES ANNOUNCES SCREENING AGREEMENT WITH F.HOFFMANN-LA ROCHE LTD | |
| DELTAGEN AND ROCHE BIOSCIENCE SIGN GENE TARGET VALIDATION AGREEMENT | |
| Axys PHARMACEUTICALS AND ROCHE BIOSCIENCE Enter FUNCTIONAL GENOMICS ALLIANCE | |
| 5/20/98: | RIBOZYME SIGNS FIRST GENETIC THERAPEUTIC TARGET DISCOVERY DEAL WITH ROCHE BIOSCIENCE |
| PANGEA SYSTEMS AND ROCHE BIOSCIENCE COMPLETE DNA CHIP DESIGN STUDY | |
| 4/9/98: | INTERNATIONALLY-RECOGNIZED ACADEMIC SCIENTISTS JOIN ROCHE BIOSCIENCE ADVISORY BOARD |
| 4/7/98: | COMBICHEM ANNOUNCES ACHIEVEMENT OF MILESTONE IN RESEARCH COLLABORATION WITH ROCHE BIOSCIENCE |
| 7/12/97: | TULARIK INC. AND ROCHE BIOSCIENCE SIGN AGREEMENT TO DEVELOP ANTI-INFLAMMATORY THERAPEUTICS THAT REGULATE PRO-INFLAMMATORY GENES |
| 6/16/97: | ROCHE BIOSCIENCE, CLONTECH ANNOUNCE RESEARCH AGREEMENT |
| 5/13/97: | RONALD H. JENKS APPOINTED CHIEF INFORMATION OFFICER FOR ROCHE PALO ALTO |
| 5/6/97: | ROCHE GAINS GLOBAL ACCESS TO ALANEX PROPRIETARY COMBINATORIAL LIBRARIES |
| 1/8/97: | ROCHE BIOSCIENCE AND AFFYMETRIX SIGN DNA CHIP AGREEMENT FOR GENE EXPRESSION MONITORING |
| 11/7/96: | COMBICHEM, INC., AND ROCHE BIOSCIENCE SIGN MAJOR DRUG DISCOVERY COLLABORATION AGREEMENT |
| 9/30/96: | ROCHE BIOSCIENCE AND ARQULE FORM COLLABORATION |
| 9/18/96: | ROCHE BIOSCIENCE, SIGNAL PHARMACEUTICALS FORM THREE-YEAR RESEARCH ALLIANCE |
| 7/31/96: | ROCHE BIOSCIENCE, LEUKOSITE ANNOUNCE RESEARCH ALLIANCE |
| 7/17/96: | ALANEX AND ROCHE BIOSCIENCE FORM COLLABORATION |
| 6/12/96: | ROCHE BIOSCIENCE TO COLLABORATE WITH UNIVERSITY COLLEGE LONDON IN NEURO-PHARMACOLOGY RESEARCH |
| 3/26/96: | ROCHE BIOSCIENCE, CLONTECH ANNOUNCE RESEARCH ALLIANCE |
| 3/19/96: | DR. JAMES N. WOODY APPOINTED PRESIDENT OF ROCHE BIOSCIENCE |
| 2/5/96: | ROCHE BIOSCIENCE FORMS RESEARCH COLLABORATIONS WITH TWO CHINESE ACADEMY OF SCIENCES INSTITUTES |
